Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8861-8870 of 13616

Page
per page
  1. Cisplatin
    A8321 Cisplatin
     39 Citation
    Summary: chemotherapeutic compound
  2. AZD-5438
    A8326 AZD-5438
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK1/2/9 inhibitor
      insoluble in H2O; ≥18.55 mg/mL
  3. Cytarabine
    A8405 Cytarabine
     1 Citation
    Summary: cytotoxic agent, blocks DNA synthesis
      insoluble in EtOH; ≥28.6 mg/mL
  4. RO4987655
    B3261 RO4987655
    Summary: MEK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥56.6 mg/mL
  5. WYE-125132 (WYE-132)
    B1642 WYE-125132 (WYE-132)
    Target: mTOR
    Summary: ATP-competitive mTOR inhibitor, highly potent
      insoluble in EtOH; insoluble in H2O; ≥13 mg/mL
  6. Ambrisentan
    B2075 Ambrisentan
    Target: ETA Receptors
    Summary: ETA-receptor antagonist
      insoluble in H2O; ≥18.92 mg/mL
  7. Amsacrine
    B1302 Amsacrine
    Summary: Topoisomerase 2 inhibitor
      ≥26.5 mg/mL
  8. TRH Precursor Peptide
    A1037 TRH Precursor Peptide
    Summary: Thyrotropin Releasing Hormone Precursor Peptide
      ≥100.6 mg/mL
  9. INH14
    B8509 INH14
    Summary: Inhibitor of IKKα/β-dependent TLR inflammatory responses
      ≥36 mg/mL
  10. BMS-582949
    B6187 BMS-582949
    Summary: p38 MAPK inhibitor
      Soluble in DMSO

Items 8861-8870 of 13616

Page
per page